Tag Archives: ivermectin

Anti-vaxxer defamation lawsuit against Houston Methodist dismissed

Posted on February 2, 2023 by Charles Kuffner

Of interest. A state district judge has dismissed Dr. Mary Talley Bowden’s defamation lawsuit against Houston Methodist Hospital, which suspended the doctor’s privileges in late 2021 over COVID misinformation. Judge Mike Engelhart, of the 151st Civil District Court, heard arguments Monday afternoon after the … Continue reading →

Posted in Legal matters | Tagged , , , , , , , , | Comments Off on Anti-vaxxer defamation lawsuit against Houston Methodist dismissed

Yeah, ivermectin is useless against COVID

Posted on March 27, 2022 by Charles Kuffner

Hardly a surprise. Antiparasitic drug Ivermectin became a partisan battleground during the Covid-19 pandemic, as anti-vaccine influencers and Republican politicians hawked it as a miracle cure, to the widespread skepticism of infectious disease experts. A peer-reviewed study recently presented by Dr. Edward Mills, a professor … Continue reading →

Posted in Technology, science, and math | Tagged , , , , | Comments Off on Yeah, ivermectin is useless against COVID

Sure, go ahead, test ivermectin

Posted on March 7, 2022 by Charles Kuffner

Just keep your expectations very low. Texas universities, including Texas Tech’s Health Science Center in El Paso, are now recruiting subjects for a nationwide study to test the effects of unproven repurposed drugs against non-severe COVID cases. Ivermectin, an anti-parasitic … Continue reading →

Posted in Technology, science, and math | Tagged , , , , , , | Comments Off on Sure, go ahead, test ivermectin

Readin’ and writin’ and gettin’ COVID

Posted on August 30, 2021 by Charles Kuffner

Welcome back to school, kids. Positive COVID-19 cases among Texas public school students rose by more than 9,000 last week, the highest number ever recorded in a seven-day period, state data shows. As of Aug. 22, there were 14,033 reports … Continue reading →

Posted in The great state of Texas | Tagged , , , , , , , , , | 4 Comments